HomeADPT ⢠NASDAQ
add
Adaptive Biotechnologies Corp
Previous close
$15.64
Day range
$14.85 - $15.94
Year range
$6.26 - $20.74
Market cap
2.40B USD
Avg Volume
2.06M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 71.68M | 51.04% |
Operating expense | 44.47M | 11.00% |
Net income | -13.58M | 59.70% |
Net profit margin | -18.94 | 73.32% |
Earnings per share | -0.09 | 60.46% |
EBITDA | -8.37M | 71.53% |
Effective tax rate | â | â |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 226.98M | 2.11% |
Total assets | 512.74M | -4.94% |
Total liabilities | 287.74M | -14.59% |
Total equity | 225.00M | â |
Shares outstanding | 153.78M | â |
Price to book | 11.01 | â |
Return on assets | -6.37% | â |
Return on capital | -7.48% | â |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -13.58M | 59.70% |
Cash from operations | â | â |
Cash from investing | â | â |
Cash from financing | â | â |
Net change in cash | â | â |
Free cash flow | â | â |
About
CEO
Founded
2009
Headquarters
Website
Employees
619
